John Ding MD PhD
@ibd_johnd
Associate Professor, Gastroenterologist - IBD, microbiome, Co-founder Medcompanion.com.au (digital tool - management of IBD and bowel preparation)
ID: 2822482797
http://Medcompanion.com.au 11-10-2014 11:20:03
1,1K Tweet
1,1K Takipçi
1,1K Takip Edilen
New ECCO CD guidelines. Hugely proud to have led with @HannahGordon Pär Myrelid @MichelAdaminamassive team effort from >50 clinicians, patients & methodologists representing 19 countries& 4 continents. A thread on what we did &why it does (&doesn’t) matter. doi.org/10.1093/ecco-j…
Thank you Milton Dick for meeting with Peter, John Ding MD PhD (Bowel Cancer Australia spokesperson) and Steff Bansemer-Brown (Bowel Cancer Australia) yesterday, as Peter and Steff shared their empowering stories and we advocated for important policy change in relation to early-onset
Thank you Richard Marles for meeting with us this week, as Jess and Kate shared their empowering lived experiences and we advocated for important policy change in relation to early-onset #BowelCancer for Bowel Cancer Australia’s #CallOnCanberra2024. #BowelCancerAustralia
It was an honour as the medical spokesperson for BowelCancerAustralia to meet with our Deputy Prime Minister to further the cause of early onset bowel cancer. Thanks BowelCancerAustralia
As the medical spokesperson for BowelCancerAustralia this is very exciting news and hopefully more Australians will take this opportunity to get screened!
We are pleased to share the clinical results of the PREDICT-UC study investigating infliximab dose strategies in ASUC. Thank you to The Lancet Gastroenterology & Hepatology for sharing our research. The full paper can be freely accessed via this link sciencedirect.com/science/articl… Christopher Li Wai Suen Austin Health
Harms in IBD RCTs. Please read our induction and maintenance studies here with thx Alexander Ford DrShahidaDin Beatriz Gros Dr Jonny Blackwell Chris Black thelancet.com/journals/langa… thelancet.com/journals/langa…
Our article on protocolising care through medical and surgical treatment for fistulising Crohn's disease demonstrates that targeting different stages of disease is important➡️⬆️radiologic healing in 25%. Thanks to patients and our team. academic.oup.com/ecco-jcc/advan… Australia New Zealand IBD Consortium (ANZIBDC)
You are into #IBD, not at the #ECCO congress and have FOMO? 🤔 Well, you may be right...😉😉 Y-ECCO Seb Florian Rieder Axel Dignass Irina Blumenstein Iago Rodriguez-Lago Sophie Restellini Aline Charabaty, MD, FACG, AGAF Beatriz Gros Fernando Magro alessandro armuzzi Isabelle Cleynen ignacio catalan John Ding MD PhD Fernando Gomollón
Happy to share our study! After 4 weeks in active Crohn's - emulisifers within healthy diet have no impact on intestinal inflammation - a healthy diet ⬇️ sonographic inflammation, ⬇️fatigue, ⬆️quality of life, ⬆️clinical remission & improves body comp. Emma Halmos Translational Medicine at Monash University
Age should not be a barrier for a #bowelcancer diagnosis!@BowelCancerAust continuing to raise awareness of #earlyonsetbowelcancer. Know your body. Act on symptoms and never be told your #tooyoung. 🙏Sarah Navin
What happens to our patients after faecal diversion with Crohn’s disease Check out our latest paper here: onlinelibrary.wiley.com/doi/10.1111/17… Thanks to co-authors John Ding MD PhD #imogenhartley
Another passion of mine is supporting bowel cancer research and raising awareness of bowel cancer! Particularly early onset bowel cancer which sadly Australia has the highest rates in the world. Thanks BowelCancerAustralia